Trial Profile
Multicenter, Randomized, Open and Sequential Study to Evaluate the Efficacy and Safety of Bemiparin Administration on the Response to Treatment in Patients Diagnosed With Limited Small Cell Lung Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2019
Price :
$35
*
At a glance
- Drugs Bemiparin sodium (Primary) ; Carboplatin; Cisplatin; Etoposide
- Indications Embolism and thrombosis; Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ABEL
- 07 Jun 2012 Additional lead trial investigator (Font A) added as reported by ClinicalTrials.gov.
- 05 Jun 2012 Final results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 21 Oct 2011 Final results were presented at the XIII National Congress of the Spanish Society of Medical Oncology, and also in a Laboratorios Farmaceuticos Rovi media release.